ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,385Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 31

$976K Total Retail Price of All Prescriptions

Rank: 2 out of 31

567 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 567 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

21% of this provider’s 567 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 11,634 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
AMLODIPINE BESYLATE 691 563 1 3
HYDROCODONE-ACETAMINOPHEN 495 215 S3 2 4
FUROSEMIDE 395 272 3 6
OMEPRAZOLE 392 268 4 1
LOVASTATIN 380 330 5 43
WARFARIN SODIUM 334 303 6 17
ZOLPIDEM TARTRATE 323 207 7 21
METFORMIN HCL 322 216 8 8
BENAZEPRIL HCL 313 254 9 53
METOPROLOL SUCCINATE 283 168 10 12
POTASSIUM CHLORIDE 270 208 11 10
LEVOTHYROXINE SODIUM 263 184 12 7
MELOXICAM 257 183 13 50
SIMVASTATIN 256 173 14 2
GABAPENTIN 249 174 15 14
DOXAZOSIN MESYLATE 226 145 16 56
CITALOPRAM HBR 220 182 17 23
GLIPIZIDE XL 216 169 18 51
CARVEDILOL 212 151 19 30
FENOFIBRATE 198 117 20 62
AMLODIPINE BESYLATE-BENAZEPRIL 197 159 21 42
PANTOPRAZOLE SODIUM 193 140 22 57
TRAMADOL HCL 192 152 23 16
NEXIUM 188 94 24 19
HYDROCHLOROTHIAZIDE 187 131 25 11
ATORVASTATIN CALCIUM 181 124 26 15
ALLOPURINOL 177 167 27 29
SYNTHROID 173 121 28 32
BENAZEPRIL-HYDROCHLOROTHIAZIDE 162 136 29 135
METOPROLOL TARTRATE 161 81 30 13
TRAZODONE HCL 152 83 31 25
KLOR-CON 8 147 128 32 141
CRESTOR 145 92 33 20
RANITIDINE HCL 125 108 34 34
CLOPIDOGREL 122 98 35 24
LISINOPRIL 122 76 35 5
OXYCODONE HCL-ACETAMINOPHEN 119 43 S2 37 86
CYMBALTA 115 59 38 78
BUPROPION HCL SR 110 71 39 157
NAPROXEN 109 86 40 69
ALENDRONATE SODIUM 108 108 41 52
TOPIRAMATE 105 30 42 160
SPIRIVA 104 54 43 91
FLUTICASONE PROPIONATE 102 68 44 59
GEMFIBROZIL 102 87 44 161
TAMSULOSIN HCL 100 63 46 28
SERTRALINE HCL 100 63 46 39
CARISOPRODOL 99 28 R 48 113
GLIPIZIDE ER 99 63 48 162
OXYCODONE HCL 98 22 S2 50 96
PREDNISONE 97 70 51 46
AMITRIPTYLINE HCL 92 55 R 52 94
GLYBURIDE-METFORMIN HCL 90 76 R 53 92
CELEBREX 90 62 53 88
ROPINIROLE HCL 90 53 53 103
PROAIR HFA 87 38 56 55
NABUMETONE 86 52 57 167
DONEPEZIL HCL 85 78 58 38
ADVAIR DISKUS 85 49 58 49
HUMULIN 70-30 85 69 58 133
ESCITALOPRAM OXALATE 85 23 58 65
PLAVIX 84 62 62 35
PAROXETINE HCL 83 50 63 72
METHOCARBAMOL 82 44 R 64 170
VERAPAMIL ER 81 68 65 116
GLIMEPIRIDE 80 63 66 26
PRAVASTATIN SODIUM 79 64 67 9
MIRTAZAPINE 79 61 67 100
LOSARTAN-HYDROCHLOROTHIAZIDE 77 77 69 31
FLUOXETINE HCL 74 18 70 77
AZITHROMYCIN 73 46 71 33
PROMETHAZINE HCL 72 23 R 72 74
TORSEMIDE 71 55 73 144
ZETIA 69 55 74 73
FINASTERIDE 69 67 74 93
METHADONE HCL 68 33 S2 76 127
DIGOXIN 67 67 77 66
VENLAFAXINE HCL ER 65 29 78 182
TESTOSTERONE CYPIONATE 65 13 S3 78 182
OXYCONTIN 64 25 S2 80 185
ISOSORBIDE MONONITRATE ER 62 45 81 79
OXYCODONE-ACETAMINOPHEN 59 32 S2 82 37
TERAZOSIN HCL 57 49 83 122
AMOXICILLIN 57 35 83 75
CIPROFLOXACIN HCL 56 40 85 61
LOSARTAN POTASSIUM 55 53 86 27
NIFEDIPINE ER 52 40 87 68
FAMOTIDINE 52 31 87 107
TRIAMTERENE-HCTZ 52 44 87 79
POLYETHYLENE GLYCOL 3350 52 30 87 44
BUSPIRONE HCL 51 21 91 208
DIOVAN 50 40 92 45
DOXYCYCLINE HYCLATE 50 24 92 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.